The short version
- Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- What the evidence isThe human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
- What to watchYellow skin or eyes, or pale stools.
How Ovagen works
Liver, GI and immune bioregulator — proposed to support hepatic/intestinal protein synthesis and detox-related function.
Start with the thing that is wrong on every page selling this. Ovagen is sold as a liver and gut bioregulator.
The molecule itself. Three residues, Glu-Asp-Leu, formula C15H25N3O8, average mass 375.39 Da. Two acidic side chains plus the C-terminal carboxyl against one protonated N-terminal amine gives a computed net charge near −2.06 at blood pH and an isoelectric point of 3.55.
- Injectable
On the goal map: Endocrine & reproductive (Organ-specific bioregulation)
Research on Ovagen5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
The human record is Soviet and post-Soviet clinical work — real patients and real endpoints, published in Russian and rarely replicated to Western standards.
Correlative data
Sold for liver, gut and immune support — a broad positioning that is broad because the peptide was isolated from tissue serving all three, not because three separate effects have been shown.
How the mechanism reads
Glu-Asp-Leu — a synthetic tripeptide proposed to support hepatic and intestinal protein synthesis.
MechanisticThe shared claim across the Khavinson series: peptides this short are proposed to enter the cell nucleus and bind promoter regions of DNA, shifting tissue-specific gene expression.
MechanisticLiver is the tissue with the clearest available readout in the whole series — ALT, AST and GGT are on every routine panel, so anyone using this can generate their own before-and-after data at near-zero cost. That is worth doing regardless of what the label claims.
Mechanistic
Sources
- Fedoreyeva LI, et al. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Moscow) 2011;76(11):1210–1219 · PMID 22117547
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Zamorskii II, Shchudrova TS, Lin'kova NS, Nichik TE, Khavinson VKh. Nephroprotective Effect of EDL Peptide at Acute Injury of Kidneys of Different Genesis. Bulletin of Experimental Biology and Medicine 2017;163(3):389–393 · PMID 28744634
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
- Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG. Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters. Biomolecules 2023;13(3):552 · PMID 36979488
- Kolchina N, Khavinson V, Linkova N, Yakimov A, Baitin D, Afanasyeva A, Petukhov M. Systematic search for structural motifs of peptide binding to double-stranded DNA. Nucleic Acids Research 2019;47(20):10553–10563 · PMID 31598715
- Alsulaimani RA, Quinn TJ (independent — not the Khavinson group). The efficacy and safety of animal-derived nootropics in cognitive disorders: Systematic review and meta-analysis. Cerebral Circulation – Cognition and Behavior 2021;2:100012 · PMID 36324709
Ovagen safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Chronic hepatitis, cirrhosis or any liver mass: a signal proposed to raise hepatic protein synthesis is unstudied there.
- Pregnancy or breastfeeding: no human data for this liver bioregulator.
- Active autoimmune disease: the school also claims immune effects that are untested.
- Under 18: organ-targeted peptide signaling in growing tissue is untested.
What’s expected
- Probably no felt effect, since the claimed action is on organ gene expression.
- Mild local skin reaction where it is applied.
- Possible small changes in digestion.
Watch for
- Yellow skin or eyes, or pale stools.
- Right upper belly pain.
- Persistent change in bowel habits.
- Rash or swelling.
Labs that tell you it’s working
- Comprehensive Metabolic Panel (CMP)
- Enhanced Liver Fibrosis (ELF) Test
- Ferritin
- hs-CRP (C-Reactive Protein, High Sensitivity)
Ovagen is a Khavinson-school liver and gut peptide with limited Russian studies; liver labs are the logical readout for its claim.
Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Ovagen FAQ4 common questions
- Is Ovagen approved for human use?
- No. Ovagen is a research compound.
- What is Ovagen researched for?
- Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
- Which labs show whether it's doing anything?
- Comprehensive Metabolic Panel; Enhanced Liver Fibrosis; Ferritin; hs-CRP: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Ovagen: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



